NASDAQ: EXEL · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Exelixis Inc.

How Exelixis Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$16.4B

Price

$66.20

P/E

19.2

EPS (TTM)

$3.62

1-year return

78.2%

Dividend yield

0.0%

52-week range

$37.90–$69.39

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources